Effects of Modified Low-Density Lipoproteins and Fenofibrate on an Outer Blood-Retina Barrier Model: Implications for Diabetic Retinopathy

Purpose: There is a lack of treatment for early diabetic retinopathy (DR), including blood-retina barrier (BRB) breakdown. The robust clinical benefit of fenofibrate in DR provides an opportunity to explore disease mechanisms and therapeutic targets. We have previously found that modified lipoprotei...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Ocul Pharmacol Ther
Glavni autori: Fu, Dongxu, Yu, Jeremy Y., Connell, Anna R., Hookham, Michelle B., McLeese, Rebecca H., Lyons, Timothy J.
Format: Artigo
Jezik:Inglês
Izdano: Mary Ann Liebert, Inc., publishers 2020
Teme:
Original Articles
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7757531/
https://ncbi.nlm.nih.gov/pubmed/33107777
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/jop.2020.0068
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items